Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

1998 update on antiphospholipid antibodies

M Petri1

  • 1Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Current Opinion in Rheumatology
|September 25, 1998
PubMed
Summary

Antiphospholipid antibodies are a common cause of hypercoagulability. Recent research advances protein targets, clinical understanding of antiphospholipid antibody syndrome, and treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Collapse of Nuclear Collectivity along the N=Z Line.

Physical review letters·2026
Same author

Author Correction: An asymmetric fission island driven by shell effects in light fragments.

Nature·2025
Same author

An asymmetric fission island driven by shell effects in light fragments.

Nature·2025
Same author

Electromagnetic properties of nuclei from first principles: a case for synergies between experiment and theory.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2024
Same author

Study of the N=32 and N=34 Shell Gap for Ti and V by the First High-Precision Multireflection Time-of-Flight Mass Measurements at BigRIPS-SLOWRI.

Physical review letters·2023
Same author

The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort.

Seminars in arthritis and rheumatism·2020

Area of Science:

  • Immunology
  • Hematology
  • Rheumatology

Background:

  • Antiphospholipid antibodies are a significant cause of acquired hypercoagulability.
  • They affect patients with systemic lupus erythematosus and those without connective tissue disease.

Purpose of the Study:

  • To summarize recent advancements in the understanding and management of antiphospholipid antibodies and antiphospholipid antibody syndrome.
  • To highlight progress in identifying protein targets and refining treatment strategies.

Main Methods:

  • Review of recent clinical research.
  • Analysis of laboratory studies.
  • Synthesis of findings from clinical trials.

Main Results:

  • Significant progress in identifying protein targets for antiphospholipid antibodies.
  • Enhanced understanding of the clinical manifestations of antiphospholipid antibody syndrome.
  • New insights into effective treatment options derived from clinical trials.

Conclusions:

  • The field of antiphospholipid antibodies is rapidly advancing.
  • Continued research is crucial for improving patient outcomes in antiphospholipid antibody syndrome.
  • Multidisciplinary approaches combining clinical and laboratory findings are essential.

Related Experiment Videos